pravastatin has been researched along with Angor Pectoris in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (33.33) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arao, K; Fujita, H; Horie, Y; Ikeda, N; Kawakami, M; Momomura, SI; Sugimura, H; Umemoto, T; Yasu, T | 1 |
| Lee, CW; Park, SJ | 1 |
| Fukui, K; Hibi, K; Kunishima, T; Michishita, I; Morino, Y; Nozue, T; Onishi, Y; Sozu, T; Takeyama, Y; Terashima, M; Tohyama, S; Umezawa, S; Yamamoto, S; Yamauchi, T | 1 |
| Shen, J; Zhang, Q; Zhang, RY | 1 |
| Akahori, H; Eguchi, A; Fujii, K; Fukunaga, M; Iwasaku, T; Kawasaki, D; Lee-Kawabata, M; Masutani, M; Masuyama, T; Ohyanagi, M; Oka, K; Sawada, H; Tsujino, T | 1 |
| Saito, Y; Sasaki, N; Shinomiya, M; Shirai, K; Yoshida, S | 1 |
| Böhm, M; Faul, A; Hennen, B; Nickenig, G; Scheller, B; Wassmann, S | 1 |
| Arai, H; Matsuo, K; Miura, S; Nishikawa, H; Saku, K; Shimomura, H; Tsuchiya, Y; Zhang, B | 1 |
| Cheng, B; Qi, BL; Zhang, QH | 1 |
| Dincer, I; Erol, C; Ertas, F; Ongun, A; Ozdol, C; Turhan, S | 1 |
| Goto, Y; Kanda, M; Kinoshita, H; Miyazaki, S; Nagaya, N; Nonogi, H; Yasuda, S | 1 |
| Anazawa, T; Fuji, T; Hirayama, A; Kanmatsuse, K; Kawamata, H; Kushiro, T; Matsumoto, M; Nagao, K; Onikura, M; Sato, Y; Tachibana, E; Tani, S; Watanabe, I | 1 |
| Bruschke, AV; Crijns, HJ; Jukema, JW; Lie, KI; van Boven, AJ; Zwinderman, AH | 1 |
| Aengevaeren, WR; Bruschke, AV; Jukema, JW; Uijen, GJ; van der Werf, T | 1 |
| Hellstrom, HR | 1 |
| Jax, TW; Leschke, M; Schoebel, FC; Strauer, BE | 1 |
| Arntz, HR | 1 |
| Becker, SL; Marschner, IC | 1 |
| Auer, J; Eber, B | 1 |
| Bouhour, JB; Chevallier, JC; Le Marec, H; Raimondeau, J | 1 |
2 review(s) available for pravastatin and Angor Pectoris
| Article | Year |
|---|---|
Evidence for the benefit of early intervention with pravastatin for secondary prevention of cardiovascular events.
Topics: Angina Pectoris; Anticholesteremic Agents; Coronary Artery Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Pravastatin; Recurrence | 1999 |
A clinical focus on statins.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Cost-Benefit Analysis; Down-Regulation; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Multicenter Studies as Topic; Myocardial Infarction; Practice Guidelines as Topic; Pravastatin; Pyrroles; Quality of Life; Randomized Controlled Trials as Topic; Simvastatin | 2001 |
9 trial(s) available for pravastatin and Angor Pectoris
| Article | Year |
|---|---|
C-reactive protein and future cardiovascular events in statin-treated patients with angina pectoris: the extended TRUTH study.
Topics: Aged; Angina Pectoris; C-Reactive Protein; Cardiovascular Diseases; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Japan; Male; Middle Aged; Myocardial Infarction; Plaque, Atherosclerotic; Pravastatin; Prospective Studies; Quinolines; Regression Analysis; Risk Factors; Treatment Outcome; Ultrasonography, Interventional | 2013 |
[Impact of statins on clopidogrel platelet inhibition in patients with acute coronary syndrome or stable angina].
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Angina Pectoris; Atorvastatin; Clopidogrel; Drug Interactions; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Pravastatin; Prospective Studies; Pyrroles; Ticlopidine | 2008 |
The impact of pravastatin pre-treatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Biomarkers; Chi-Square Distribution; Coronary Angiography; Coronary Circulation; Coronary Stenosis; Creatine Kinase, MB Form; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Linear Models; Logistic Models; Male; Microcirculation; Middle Aged; Pravastatin; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Troponin I; Ultrasonography, Interventional; Vascular Resistance | 2011 |
Prognosis of hypercholesterolemic patients taking pravastatin for five years: the Chiba Lipid Intervention Program (CLIP) Study.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Anticholesteremic Agents; Arrhythmias, Cardiac; Cause of Death; Female; Follow-Up Studies; Heart Failure; Humans; Hypercholesterolemia; Incidence; Lipids; Male; Middle Aged; Myocardial Infarction; Pravastatin; Prognosis; Prospective Studies; Risk Factors | 2002 |
Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function.
Topics: Aged; Angina Pectoris; Blood Flow Velocity; Blood Pressure; C-Reactive Protein; Coronary Angiography; Coronary Circulation; Coronary Vessels; Double-Blind Method; Endothelium, Vascular; Female; Heart Rate; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Middle Aged; Pravastatin; Prospective Studies; Time Factors; Vascular Patency; Vasodilation; Vasodilator Agents | 2003 |
[Comparison of effects of taizhi' an capsule and pravastatin on vascular endothelial function in senile patients with coronary heart disease].
Topics: Aged; Angina Pectoris; Carotid Arteries; Coronary Disease; Drug Therapy, Combination; Drugs, Chinese Herbal; Endothelium, Vascular; Female; Humans; Male; Phytotherapy; Pravastatin; Ultrasonography | 2004 |
Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Hypercholesterolemia; Hypertension; Life Tables; Male; Middle Aged; Myocardial Infarction; Pravastatin; Risk Factors; Smoking; Treatment Outcome | 1993 |
Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group.
Topics: Angina Pectoris; Anticholesteremic Agents; Cardiovascular Agents; Cholesterol; Drug Therapy, Combination; Electrocardiography, Ambulatory; Humans; Male; Middle Aged; Myocardial Ischemia; Pravastatin; Prospective Studies | 1996 |
Functional evaluation of lipid-lowering therapy by pravastatin in the Regression Growth Evaluation Statin Study (REGRESS)
Topics: Adult; Aged; Angina Pectoris; Anticholesteremic Agents; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Follow-Up Studies; Humans; Lipids; Middle Aged; Perfusion; Pravastatin | 1997 |
10 other study(ies) available for pravastatin and Angor Pectoris
| Article | Year |
|---|---|
Pravastatin improves postprandial endothelial dysfunction and hemorheological deterioration in patients with effort angina pectoris.
Topics: Angina Pectoris; Endothelium, Vascular; Female; Hemorheology; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Postprandial Period; Pravastatin; Vasodilation | 2017 |
Statins for treating stable angina: can statins improve the plaque morphology and angina?
Topics: Angina Pectoris; Angina, Stable; Atorvastatin; Disease Progression; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Plaque, Atherosclerotic; Pravastatin; Pyrroles; Ultrasonography, Interventional | 2013 |
Statins induce the regression of left ventricular mass in patients with angina.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Cardiomegaly; Case-Control Studies; Constriction, Pathologic; Drug Evaluation; Female; Heart Ventricles; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Middle Aged; Pravastatin; Retrospective Studies; Simvastatin | 2004 |
Effect of statin treatment on coronary collateral development in patients with diabetes mellitus.
Topics: Angina Pectoris; Atorvastatin; Cholesterol, LDL; Collateral Circulation; Coronary Angiography; Coronary Disease; Diabetes Mellitus; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Pravastatin; Pyrroles; Retrospective Studies; Simvastatin | 2006 |
Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.
Topics: Aged; Analysis of Variance; Angina Pectoris; C-Reactive Protein; Case-Control Studies; Cholesterol; Enzyme Activation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Linear Models; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Pravastatin; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Ventricular Dysfunction, Left; Ventricular Remodeling | 2007 |
A case of vasospastic angina showing resolution of coronary vasospasm in acetylcholine provocation test corresponding to regression of coronary atherosclerosis.
Topics: Acetylcholine; Angina Pectoris; Angina Pectoris, Variant; Anticholesteremic Agents; Cholinergic Agents; Coronary Artery Disease; Coronary Vasospasm; Dihydropyridines; Humans; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Ultrasonography; Vasodilator Agents | 2008 |
Prevastatin treatment in angina pectoris.
Topics: Angina Pectoris; Anticholesteremic Agents; Humans; Pravastatin | 1997 |
Functional evaluation of lipid-lowering therapy by pravastatin.
Topics: Angina Pectoris; Anticholesteremic Agents; Cholesterol, LDL; Cohort Studies; Coronary Circulation; Coronary Disease; Drug Evaluation; Electrocardiography; Endothelium, Vascular; Exercise Test; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin | 1998 |
Interim monitoring of clinical trials based on long-term binary endpoints.
Topics: Angina Pectoris; Anticholesteremic Agents; Cholesterol, HDL; Computer Simulation; Endpoint Determination; Humans; Numerical Analysis, Computer-Assisted; Pravastatin; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Research Design | 2001 |
[Biological myolysis during combined fenofibrate-pravastatin therapy].
Topics: Angina Pectoris; Creatine Kinase; Drug Therapy, Combination; Fenofibrate; Humans; Male; Middle Aged; Pravastatin; Rhabdomyolysis | 1992 |